Insights
Big plans for Little Green Pharma
Read more on the Australian firm hoping to help more UK patients benefit from medical cannabis.
Apr 2020
Another successful harvest
Company news
04 Jun 2019
Little Green Pharma successfully harvest another medical cannabis crop and pass TGO 93.
Little Green Pharma is pleased to announce the successful harvest of another medical cannabis crop at its facility in the southwest of Western Australia. The cannabis flowers have also passed the full suite of TGO 93 mandatory testing (the Regulatory Standard for Medicinal Cannabis in Australia). TGO 93 applies to any medicinal cannabis product imported into, exported from, or supplied in Australia.
Little Green Pharma is still the market leader in Australia, offering the only Australian-grown and produced medicinal cannabis products for sale to Australian patients.
Little Green Pharma’s Managing Director, Fleta Solomon said; “The cultivation team has delivered yet another high quality crop of cannabis plants ready to be manufactured into much needed medicines. As an organisation we are working hard to ensure we keep up with the growing patient demand for cannabinoid therapies in Australia and overseas.”
You might also be interested in
Company news
Transdermal technologies
Landmark collaboration to commercialise transdermal cannabis technologies
Jun 2019
Insights
Commissioning of cultivation facility expansion complete
On-time and on budget. Read more about our expansion facility here.
Mar 2020